Eric H.‐B. Huang

655 total citations
15 papers, 528 citations indexed

About

Eric H.‐B. Huang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eric H.‐B. Huang has authored 15 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Eric H.‐B. Huang's work include Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Interference and Gene Delivery (2 papers). Eric H.‐B. Huang is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA Interference and Gene Delivery (2 papers). Eric H.‐B. Huang collaborates with scholars based in United States, Canada and India. Eric H.‐B. Huang's co-authors include Jean Gariépy, Aws Abdul‐Wahid, Marzena Cydzik, Timothy F. Burns, Suman Chatterjee, Aaron Prodeus, Nicholas W. Fischer, Zachary A. Yochum, Phuoc T. Tran and Charles M. Rudin and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Controlled Release.

In The Last Decade

Eric H.‐B. Huang

15 papers receiving 524 citations

Peers

Eric H.‐B. Huang
Lotte Hiddingh United States
Tianxiao Xu China
Roi Villar-Vázquez Spain
Andrew Cannon United States
Delphine Quatannens Belgium
Hanlin Mok United States
Yanjie You China
Ashu Shah United States
Pietro Parcesepe Italy
Katriana Nugent United States
Lotte Hiddingh United States
Eric H.‐B. Huang
Citations per year, relative to Eric H.‐B. Huang Eric H.‐B. Huang (= 1×) peers Lotte Hiddingh

Countries citing papers authored by Eric H.‐B. Huang

Since Specialization
Citations

This map shows the geographic impact of Eric H.‐B. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric H.‐B. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric H.‐B. Huang more than expected).

Fields of papers citing papers by Eric H.‐B. Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric H.‐B. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric H.‐B. Huang. The network helps show where Eric H.‐B. Huang may publish in the future.

Co-authorship network of co-authors of Eric H.‐B. Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Eric H.‐B. Huang. A scholar is included among the top collaborators of Eric H.‐B. Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric H.‐B. Huang. Eric H.‐B. Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chatterjee, Suman, Nathaniel Wang, Vlad C. Sandulache, et al.. (2024). p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. BMC Cancer. 24(1). 233–233. 1 indexed citations
2.
Kumar, Vinod, Zachary A. Yochum, Eric H.‐B. Huang, et al.. (2024). TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer. Oncogene. 43(19). 1431–1444. 5 indexed citations
3.
Stabile, Laura P., Vinod Kumar, Eric H.‐B. Huang, et al.. (2020). Syngeneic tobacco carcinogen–induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden. JCI Insight. 6(3). 15 indexed citations
4.
Yochum, Zachary A., Jessica Cades, Hailun Wang, et al.. (2018). Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene. 38(5). 656–670. 138 indexed citations
5.
6.
Yochum, Zachary A., Jessica Cades, Lucia Mazzacurati, et al.. (2017). A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer. Molecular Cancer Research. 15(12). 1764–1776. 69 indexed citations
7.
Chatterjee, Suman, et al.. (2017). Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS- Mutant NSCLC Is Mediated via Reactivation of the ERK–p90RSK–mTOR Signaling Network. Molecular Cancer Therapeutics. 16(5). 793–804. 40 indexed citations
8.
Mittal, Rahul, James M. Parrish, Eric H.‐B. Huang, et al.. (2017). Local drug delivery in the urinary tract: current challenges and opportunities. Journal of drug targeting. 26(8). 658–669. 12 indexed citations
9.
10.
Abdul‐Wahid, Aws, Marzena Cydzik, Aaron Prodeus, et al.. (2016). Induction of antigen‐specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment. International Journal of Cancer. 139(4). 841–853. 43 indexed citations
11.
Prodeus, Aaron, Aws Abdul‐Wahid, Nicholas W. Fischer, et al.. (2015). Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers. Molecular Therapy — Nucleic Acids. 4. e237–e237. 117 indexed citations
12.
Abdul‐Wahid, Aws, Eric H.‐B. Huang, Marzena Cydzik, Eleonora Bolewska‐Pedyczak, & Jean Gariépy. (2013). The carcinoembryonic antigen IgV‐like N domain plays a critical role in the implantation of metastatic tumor cells. Molecular Oncology. 8(2). 337–350. 13 indexed citations
13.
Abdul‐Wahid, Aws, et al.. (2013). Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti‐adhesive properties against the carcinoembryonic antigen. Molecular Oncology. 7(4). 799–811. 19 indexed citations
14.
Abdul‐Wahid, Aws, et al.. (2012). A focused immune response targeting the homotypic binding domain of the carcinoembryonic antigen blocks the establishment of tumor foci in vivo. International Journal of Cancer. 131(12). 2839–2851. 13 indexed citations
15.
Abdul‐Wahid, Aws, et al.. (2012). The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP–protein cargos to the cytosol of eukaryotic cells. Journal of Controlled Release. 164(1). 58–64. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotte Hiddingh Breakdown of academic impact, for papers by Tianxiao Xu Breakdown of academic impact, for papers by Roi Villar-Vázquez Breakdown of academic impact, for papers by Andrew Cannon Breakdown of academic impact, for papers by Delphine Quatannens Breakdown of academic impact, for papers by Hanlin Mok Breakdown of academic impact, for papers by Yanjie You Breakdown of academic impact, for papers by Ashu Shah Breakdown of academic impact, for papers by Pietro Parcesepe Breakdown of academic impact, for papers by Katriana Nugent
Rankless by CCL
2026